Q4 2020 Holdings
Filed 2021-02-16 | 85 holdings | $432.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2021-02-19) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | COM | 00287Y109 | $99.3M | 926,823 | 22.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $87.6M | 3,373,460 | 20.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $67.3M | 1,259,474 | 15.6% |
| Avantor Inc(AVTR) | COM | 05352A100 | $58.4M | 2,074,259 | 13.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $28.1M | 114,604 | 6.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $27.6M | 314,499 | 6.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $20.2M | 971,151 | 4.7% |
| Centene Corp del(CNC) | COM | 15135B101 | $19.7M | 328,479 | 4.6% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $14.5M | 2,694,769 | 3.4% |
| Certara Inc(CERT) | COM | 15687V109 | $7.7M | 228,000 | 1.8% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $153.3K | 981,131 | 0.0% |
| Outset MED Inc(OMGBP)A | COM | 690145107 | $150.6K | 2,911,207 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $97.2K | 1,328,803 | 0.0% |
| ARK ETF TR(ARKG)Put | GENOMIC REV ETF | 00214Q302 | $83.9K | 900,000 | 0.0% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $66.9K | 373,301 | 0.0% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $60.8K | 442,044 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $59.2K | 350,645 | 0.0% |
| ICU MED Inc(ICUI) | COM | 44930G107 | $57.4K | 267,817 | 0.0% |
| Moderna Inc(MRNA)Put | COM | 60770K107 | $56.4K | 540,000 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $54.9K | 941,674 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $54.7K | 1,094,600 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $54.0K | 311,940 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $53.7K | 308,987 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $52.7K | 164,238 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $51.6K | 313,487 | 0.0% |
| Aerie Pharmaceuticals Inc | NOTE 1.500%10/0 | 00771VAB4 | $48.0K | $51,850,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN)Call | COM | 015351109 | $46.9K | 300,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $45.9K | 209,006 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $44.5K | 487,842 | 0.0% |
| Biomarin Pharmaceutical Inc | NOTE 0.599% 8/0 | 09061GAH4 | $43.2K | $40,300,000 | 0.0% |
| Novavax Inc | NOTE 3.750% 2/0 | 670002AB0 | $43.0K | $34,000,000 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $42.6K | 2,011,477 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $40.6K | 171,028 | 0.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $39.4K | 986,019 | 0.0% |
| Biogen Inc(BIIB)Call | COM | 09062X103 | $39.2K | 160,000 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $38.0K | 171,252 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $35.8K | 102,099 | 0.0% |
| Select Sector Spdr TR(XLF)Call | SBI INT-FINL | 81369Y605 | $35.0K | 1,188,100 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $34.9K | 199,694 | 0.0% |
| Biomarin Pharmaceutical Inc(BMRN)Call | COM | 09061G101 | $32.6K | 371,700 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $31.9K | 77,740 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $30.1K | 2,227,611 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $29.4K | 227,876 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $28.9K | 1,046,212 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $28.0K | 451,275 | 0.0% |
| Henry Schein Inc(HSIC) | COM | 806407102 | $26.4K | 395,161 | 0.0% |
| Laboratory Corp Amer Hldgs | COM NEW | 50540R409 | $26.1K | 128,100 | 0.0% |
| PPD Inc | COM | 69355F102 | $25.4K | 742,863 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $25.2K | 685,125 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $24.1K | 215,908 | 0.0% |